Is Heartbeam Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: BEAT) stock is to Buy BEAT stock.
Out of 1 analyst, 0 (0%) are recommending BEAT as a Strong Buy, 1 (100%) are recommending BEAT as a Buy, 0 (0%) are recommending BEAT as a Hold, 0 (0%) are recommending BEAT as a Sell, and 0 (0%) are recommending BEAT as a Strong Sell.
What is BEAT's forecast return on equity (ROE) for 2024-2027?
(NASDAQ: BEAT) forecast ROE is N/A, which is considered weak.
What is BEAT's Price Target?
According to 1 Wall Street analyst that have issued a 1 year BEAT price target, the average BEAT price target is $8.00, with the highest BEAT stock price forecast at $8.00 and the lowest BEAT stock price forecast at $8.00.
The Wall Street analyst predicted that Heartbeam's share price could reach $8.00 by Sep 4, 2025. The average Heartbeam stock price prediction forecasts a potential upside of 253.98% from the current BEAT share price of $2.26.
What is BEAT's forecast return on assets (ROA) for 2024-2027?
(NASDAQ: BEAT) forecast ROA is N/A, which is lower than the forecast US Health Information Services industry average of 9.63%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.